Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Treating premenstrual dysphoric disorder using serotonin agents
Autore:
Lin, J; Thompson, DS;
Indirizzi:
Western Psychiat Inst & Clin, Pittsburgh, PA USA Western Psychiat Inst & Clin Pittsburgh PA USA Clin, Pittsburgh, PA USA Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA Univ Pittsburgh Pittsburgh PA USA rgh, Dept Psychiat, Pittsburgh, PA USA Univ Pittsburgh, Behav Med Clin Serv, Pittsburgh, PA USA Univ Pittsburgh Pittsburgh PA USA ehav Med Clin Serv, Pittsburgh, PA USA Magee Womens Hosp, Pittsburgh, PA USA Magee Womens Hosp Pittsburgh PA USA agee Womens Hosp, Pittsburgh, PA USA
Titolo Testata:
JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE
fascicolo: 8, volume: 10, anno: 2001,
pagine: 743 - 750
SICI:
1524-6094(200110)10:8<743:TPDDUS>2.0.ZU;2-A
Fonte:
ISI
Lingua:
ENG
Soggetto:
RANDOMIZED CONTROLLED TRIAL; PHASE SERTRALINE TREATMENT; LUTEAL-PHASE; MOOD DISORDERS; DOUBLE-BLIND; FLUOXETINE TREATMENT; GONADAL-STEROIDS; MENSTRUAL-CYCLE; WOMEN; DEPRESSION;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Social & Behavioral Sciences
Clinical Medicine
Citazioni:
78
Recensione:
Indirizzi per estratti:
Indirizzo: Thompson, DS Dept Psychiat, 1356 Lusitana St, Honolulu, HI 96813 USA Dept Psychiat 1356 Lusitana St Honolulu HI USA 96813 6813 USA
Citazione:
J. Lin e D.S. Thompson, "Treating premenstrual dysphoric disorder using serotonin agents", J WOMEN H G, 10(8), 2001, pp. 743-750

Abstract

Premenstrual syndrome (PMS) affects 20%-50% of all women. Premenstrual dysphoric disorder (PMDD), which can be conceptualized as a more severe variant of PMS, can affect 3%-9% of all women. Because a significant number of women suffer from premenstrual disorders and afflicted women may spend up to half the month suffering from symptoms, it is important to identify and provide effective treatment for such women. Historically, it has been difficult to distinguish premenstrual disorders from other depressive disorders, given the high comorbidity of the two disorders. Most studies attempt to remove this confounding factor by excluding women with concurrent depressive disorders. Despite the difficulties and limitations inherent in studying treatments for premenstrual disorders, most investigations support the use of serotonin agents in treating PMDD.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/01/20 alle ore 16:07:27